Innovation Has a New Address. What is it, you ask?
The answer is Healthcare now with AI. It’s no longer stuck in the ‘90s. Or just doctors and their diagnostic labs anymore. It’s AI, cloud labs, and telehealth clinics. The industry’s leveling up fast, thanks to tech and a whole lot of venture culture love. With big global challenges like accessibility, affordability, and chronic diseases hanging over our heads, the need for smarter health solutions is obvious. It’s no longer just about curing, it’s about predicting, preventing, and personalizing. The health tech industry, once a slow adopter, is now sprinting ahead, fuelled by innovation, necessity, and some serious capital.
Venture capitalists have been keeping their eyes (and checkbooks) on health tech for good reason. But startups? They’re getting smarter. From rural India to biotech labs in California, the health tech revolution is in full swing, and companies like Medprime Technologies are proving that affordability and innovation can go hand in hand.
AI In Healthcare
CureBay – Prescriptions for Rural India & Digitally Delivered
In April 2025, CureBay, a Bhubaneswar-based health tech startup, snagged a total of $21 million in Series B funding. Leading the charge was Bertelsmann India Investments, with British International Investment and loyal backer Elevar Equity tagging along for the ride. Started in 2021, CureBay isn’t playing the usual healthcare game with AI. While over 65% of India’s population lives in rural areas, many still struggle to find timely, affordable medical care.
CureBay’s solution? A smart hybrid of tech and boots-on-the-ground e-clinics that connect remote patients with specialist doctors via teleconsultation. Which, for folks who aren’t exactly tech wizards, means using technology like video, phone, or messaging to connect with an AI in healthcare that provides diagnosis or treatment remotely. No fuss, just ease.
They’re already running over 150 e-clinics across Odisha and Chhattisgarh. Now, with fresh funds in hand, they’re gearing up to storm Jharkhand, Bihar, Uttar Pradesh, and Madhya Pradesh. The cash will supercharge their tech, hire more medical pros, and crank up their AI-powered predictive care models to stop health issues before they start.
Targeting Tier 3 and 4 cities, CureBay is no startup chasing buzzwords. They’re building a bridge between the old-school healthcare system and the millions still left out in the cold. Investors are digging it because this isn’t just business. Its impact with capital letters and now with AI in healthcare.
Complement1 – Fighting Cancer with Coaching, Not Chemo
WhiteHat Jr’s former CEO, Karan Bajaj, could’ve stayed in edtech. Instead, he’s back with a vengeance, and this time, he’s taking on cancer. His new startup, Complement1, raised $16 million in seed funding, led by Owl Ventures and Blume Ventures. But this isn’t just another AI healthcare app. Complement1 is built on a hard truth: ’ lifestyle is a silent killer’. And for cancer survivors and high-risk individuals, it’s often the missing piece in recovery.
So, Complement1 flips the script. Users get evidence-based coaching for nutrition, sleep, stress, and movement tailored by data, tracked digitally, and delivered with actual human support. It’s like having a lifestyle oncologist. Which, my poor little soul, means a specialized physician who focuses on the diagnosis, treatment, and research of cancer in your pocket. This isn’t “wellness” with a fancy filter.
It’s clinically aligned with AI in healthcare, structured for impact, and designed to work alongside medical treatment, not replace it. Think of it as the bridge between chemo and change. Over 100,000 users have already jumped in during early access, and the platform is building partnerships with insurers and hospitals in the U.S. and India. Bajaj’s execution record plus a cause that cuts deep? It’s no wonder investors are betting big.
Persist AI – Turning Drug Discovery into a Digital Sprint
Drug development is slow. Painfully slow. But don’t you worry, because here I present to you “Persist AI”. A California-based startup that just bagged $12 million in Series A to change that. Yes, most of the time, money is the solution. Anyway, the idea? To automate the drug formulation process through AI in healthcare, robotics, and a platform called “Cloud Lab”. Pharma companies can run, monitor, and tweak lab experiments remotely, cutting time, cost, and human error in one go.
Right now, formulating a single drug can take months or even years. But Persist AI claims its Cloud Lab cuts that timeline by up to 70%. For an industry where every second equals millions, now isn’t that game-changing. The funding will expand their lab capacity, scale the platform, and bring in more AI firepower. Their client list already includes smaller biotech players who now suddenly have big-league R&D capabilities without an extensive budget. Persist AI isn’t just fast-tracking science. It’s handing the keys over so the underdogs can take center stage.
What’s Common? It’s AI In Healthcare
These startups couldn’t be more different in geography, scale, or strategy, but they share one critical thing. What is it? Relevance. They’re solving urgent, messy, high-stakes problems with technology that fits into people’s lives, instead of sitting in a pitch deck collecting dust.
CureBay is addressing AI in healthcare deserts in rural India, where over 65% of the population lives, but access to specialized medical care remains a luxury. By combining teleconsultations with physical e-clinics, it’s closing the gap between patients and providers in places where basic health infrastructure is still catching up.
Then we have Complement1, a brainchild of WhiteHat Jr. founder Karan Bajaj, which targets a largely ignored demographic of cancer survivors. India faces a growing cancer burden, with over 1.46 million new cases reported in 2022 and projections indicating a rise of $1.57 billion by 2025. Advancements in early detection and treatment are improving survival rates, making survivorship a critical aspect of cancer care.
It’s not just about surviving cancer anymore, it’s about surviving well. Persist AI, meanwhile, is dragging drug discovery into the 21st century with the help of AI in healthcare. Traditional drug formulation can take 10–15 years and cost upwards of $2.6 billion.
Persist AI’s Cloud Lab claims to reduce R&D timelines by up to 70%, using automation, AI, and remote experimentation to help biotech companies, especially the smaller, scrappier ones, innovate without going dry.
Each of these startups knows exactly who they’re building for. They don’t just serve users. They design with them in mind, responding to real-world constraints, behaviors, and needs. And that’s why investors are paying attention. Not because these startups are loud, but because they’re loudly relevant.
Startups Making Real Change With AI In Healthcare
These startups, aka CureBay, Complement1, and Persist AI, might play in different leagues, but they share one thing, which is real-world impact. CureBay is straight-up bridging healthcare gaps in rural India like a boss. Complement1 has cancer survivors covered from day one with the care that matters. Persist AI is turbocharging drug development, cutting the fat on time and cost. They’re not here to build fancy tech just to look good, they’re solving real problems that affect people. That’s why investors and users can’t stop paying attention. In a world full of noise, these companies are here to change the course of action.
